🏛️ Verified NIH Record • Updated 2025-09-26

A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine (NCT06899802)

A Two-stage, Randomized, Double-blind, Dose Ranging Phase 2 Trial in Healthy Adult Participants to Investigate Optimal Dose and Dosing Regimen, and to Evaluate Safety and Immunogenicity of the Recombinant MVA-BN-WEV Vaccine

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Bavarian Nordic

🩺 Plain-English Summary (8th-Grade Level)

This phase 2 clinical trial will investigate an optimal dose, dosing regimen, and evaluate reactogenicity, safety and immunogenicity in healthy adult participants of the recombinant, multivalent MVA-BN-WEV vaccine. MVA-BN-WEV is intended for active immunization for prevention of disease induced by VEEV and EEEV, in persons aged 18 years and older at high risk of exposure.

Who can join: Review the eligibility criteria below.

Location: Benchmark Research — Sacramento, California

Age range: 18 Years to 50 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (9 Sites)

  • Benchmark Research — Sacramento, California
  • Lifeline Primary Care, Inc. / CCT Research — Lilburn, Georgia
  • Johnson County Clin-Trials — Lenexa, Kansas
  • Versailles Family Medicine, PLLC/CCT Research — Versailles, Kentucky
  • Benchmark Research — Kenner, Louisiana
  • Jefferson City Medical Group / Avacare — Jefferson City, Missouri
  • Clay-Platte Family Medicine, P.C./CCT Research — Kansas City, Missouri
  • Papillion Research Center/CCT Research — Papillion, Nebraska
  • Benchmark Research — San Angelo, Texas

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Encephalitis clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗